Market Closed - Nasdaq 04:00:00 2024-07-12 pm EDT 5-day change 1st Jan Change
6.17 USD -1.44% Intraday chart for LifeMD, Inc. -6.09% -25.57%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
KeyBanc Adjusts Price Target on LifeMD to $10 From $12, Maintains Overweight Rating MT
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell Small Cap Comp Value Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell Small Cap Completeness Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 2000 Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 3000E Value Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 3000 Growth Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 3000E Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 2500 Value Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 3000 Value Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 2000 Value Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 3000E Growth Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 2000 Growth Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 2000 Dynamic Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell Microcap Value Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 2500 Growth Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell Small Cap Comp Growth Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 2500 Index CI
LifeMD, Inc.(NasdaqGM:LFMD) added to Russell 3000 Index CI
LifeMD Launching Private Health Insurance Acceptance For Primary Care Services MT
LifeMD, Inc. Launches Commercial Health Insurance Acceptance for Its Primary Care Services, Including Weight Management CI
LifeMD Files for $150 Million Mixed Shelf MT
KeyBanc Initiates LifeMD at Overweight With $12 Price Target, Cites 'Strong Top & Bottom-Line Growth' MT
Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating MT
LifeMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024
Chart LifeMD, Inc.
More charts
LifeMD, Inc. is a direct-to-patient telehealth company, which provides comprehensive virtual and in-home healthcare. The Company operates through two segments: Telehealth and WorkSimpli. Telehealth segment is engaged in telehealth platform, which integrates a clinician-centric electronic medical record (EMR) system, algorithms for case-load balancing and scheduling, customer relationship management functionality, asynchronous communication, secure synchronous, cloud pharmacy and more. Its technology platform, combined with its 50-state affiliated provider network, enables the management of virtual treatment offerings across various health conditions, including, dermatology, urgent and primary care, chronic care management, dermatology, chronic care management and other. Its WorkSimpli segment offers workplace and document services. This segment offers PDFSimpli an online software as a service platform that allows users to create, edit, convert, sign and share PDF documents.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
6.17 USD
Average target price
12.5 USD
Spread / Average Target
+102.59%
Consensus
  1. Stock Market
  2. Equities
  3. LFMD Stock
  4. News LifeMD, Inc.
  5. KeyBanc Initiates LifeMD at Overweight With $12 Price Target, Cites 'Strong Top & Bottom-Line Growth'